Flu season isn't just a public health event anymore — it's a multi-billion-dollar industry racing to stay ahead of a virus that mutates every year. As respiratory disease awareness remains elevated in the post-pandemic world, the global influenza vaccine market is entering a phase of steady, structural growth, driven by expanding immunization programs, next-generation vaccine...